Kremlin pays no attention to Kiev's protest over Putin’s trip to CrimeaRussian Politics & Diplomacy October 27, 11:17
Central Bank: Russia’s moving up in Doing Business rating as good signBusiness & Economy October 27, 11:14
Russian aid convoy arrives in DonbassWorld October 27, 10:39
Russian citizen serving time in US surprised by transfer to general wardWorld October 27, 10:13
Militants continue disrupting peace in Aleppo — Russia’s Defense MinistryWorld October 27, 8:33
Russia's UN envoy urges organization to prove Aleppo air strikes continueRussian Politics & Diplomacy October 27, 8:02
Media reports on Russian ships call into Ceuta are controversial — embassyRussian Politics & Diplomacy October 26, 22:03
Russia’s telecom watchdog tries to block LinkedIn through courtSociety & Culture October 26, 21:29
DPR envoy reports no constructive discussion on "Steinmeier formula" in MinskWorld October 26, 21:14
NOVOSIBIRSK, June 9. /TASS/. A new vaccine to protect against Ebola virus disease developed by Russia’s Vector research center of virology and biotechnology has successfully undergone the first stage of clinical tests, the acting director general of the research center told reporters on the sidelines of the international forum for technological development on Thursday.
"The first phase of clinical tests has been completed. It is now on approval at the Russian Ministry of Healthcare. We are waiting for a second phase," Valery Mikheyev said.
According to the World Health Organization (WHO), more than 11,300 people have died from Ebola in West Africa, primarily in Guinea, Sierra Leone and Liberia. More than 28,600 were infected. In January, Russia informed the WHO executive committee about its anti-Ebola vaccines.
The World Health Organization describes Ebola virus disease (formerly known as Ebola haemorrhagic fever) as "a severe, often fatal illness, with a case fatality rate of up to 90%." Until now, there has been no known cure or vaccine for the disease. The only treatment offered is "supportive intensive care." During an outbreak, those at higher risk of infection are health workers, family members and others in close contact with sick people and deceased patients.